Larvol Delta - Ampio-Pharmaceuticals-Ongoing-Phase-I-Clinical-Trial-for-Inhalation-Treatment-of-COVID19-with-Ampion-is-55-Enrolled

Ampion IV (aspartyl-alanyl diketopiperazine) - Ampio

https://www.prnewswire.com/news-releases/ampio-pharmaceuticals-ongoing-phase-i-clinical-trial-for-inhalation-treatment-of-covid-19-with-ampion-is-55-enrolled-301208409.html

Jan 14, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next